Reducing Listeria’s virulence
Listeria has been in the news a lot lately — five elderly Australians have died after eating contaminated rockmelons, at least 183 South Africans have died after eating Listeria-contaminated polony, eight are dead after eating frozen corn in Europe/UK — this is one pretty nasty bacteria.
Now researchers from North Carolina State University have identified several compounds that may be effective in containing Listeria’s virulence — or ability to produce disease. The researchers already knew that inhibiting the glucose-1-phosphate uridylyltransferase (GalU) enzyme in Listeria significantly modifies the bacterial cell surface and this, in turn, renders the Listeria much less virulent and so less able to cause illness.
The researchers turned their attention to identifying potential compounds that could inhibit the function of GalU. Using computers and cheminformatics methods, they characterised, analysed and virtually screened more than 88,000 compounds with the potential to inhibit GalU.
Computer models found 37 compounds promising enough to be tested in vitro. Of the 37, three were deemed effective enough to warrant further study.
Interestingly, inhibiting GalU also served to make the Listeria more vulnerable to cefotaxime, an antibiotic to which the bacteria are naturally resistant.
SPC Global to close facility under demand-led manufacturing strategy
SPC Global plans to close its Mill Park facility in Victoria by August 2026 and relocate...
Unlocking the benefits of avocados across the value chain
Westfalia Fruit is helping to advance the future of the avocado sector with its zero-waste,...
Risk management approach for toxin in infant formula
Following recent recalls of specific infant formula products, the European Food Safety Authority...

